OPKO's ModeX to present CAR-T cell generation data at gene therapy meeting May 12, 2026 08:00AM
OPKO Health receives 15% stake in Nicoya for China drug rights Apr 30, 2026 08:31AM
Barrington Research Downgrades Opko Health (OPK) to Market Perform Apr 29, 2026 07:38AM
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK) Apr 29, 2026 07:22AM
OPKO Health (OPK) Misses Q1 EPS by 1c, provides guidance Apr 28, 2026 04:10PM


Apr 9, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Apr 8, 2026 08:03AM OPKO Health's ModeX begins phase 1 trial of COVID-19 prevention drug
Feb 26, 2026 04:17PM OPKO Health (OPK) Tops Q4 EPS by 3c, provides guidance
Feb 10, 2026 06:53AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Feb 4, 2026 08:02AM OPKO Health and Entera Bio expand partnership for oral PTH tablet
Nov 20, 2025 01:01AM JPMorgan Starts Opko Health (OPK) at Neutral
Oct 30, 2025 04:05PM Jefferies Downgrades Opko Health (OPK) to Hold
Oct 29, 2025 04:41PM OPKO Health (OPK) Tops Q3 EPS by 9c
Oct 29, 2025 08:00AM OPKO's ModeX partners with Regeneron on multispecific antibodies
Oct 28, 2025 08:04AM OPKO Health's ModeX starts cancer drug trial
Jul 31, 2025 04:48PM OPKO Health (OPK) Misses Q2 EPS by 8c
Jul 8, 2025 08:03AM OPKO Health and Entera Bio abstract selected for ESPEN Congress
Jun 30, 2025 08:02AM NextPlat Corp (NXPL) Issues Interim CEO Update Shareholder Letter
Jun 25, 2025 08:05AM OPKO Health (OPK) and Entera Bio (ENTX) Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation
Jun 9, 2025 08:04AM OPKO Health's (OPK) ModeX Therapeutics Forms Scientific Advisory Board
Apr 30, 2025 04:55PM OPKO Health (OPK) Misses Q1 EPS by 1c
Apr 25, 2025 03:01AM JPMorgan Starts Opko Health (OPK) at Neutral
Apr 8, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Apr 4, 2025 08:02AM OPKO Health (OPK) Announces $100 Million Increase to its Existing Share Repurchase Program
Mar 19, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Mar 17, 2025 08:01AM OPKO Health (OPK) and Entera Bio (ENTX) Enter into Collaboration Agreement
Mar 13, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Mar 11, 2025 07:07AM Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Feb 27, 2025 04:28PM OPKO Health (OPK) Tops Q4 EPS by 9c
Feb 24, 2025 10:09AM Increasing unusual call option volume: LFMD GDRX GFI OPK ODD PRMB DAVE SLG MO MAXN
Jan 8, 2025 09:27AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Nov 8, 2024 03:19PM OPKO Health (OPK) Tops Q3 EPS by 12c
Oct 7, 2024 08:02AM NextPlat Corp (NXPL) Secures Four-Year Extension of OPKO (OPK) Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan
Oct 7, 2024 08:00AM OPKO Health's (OPK) ModeX Therapeutics Secures $35M BARDA Supplement
Sep 26, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Sep 25, 2024 08:31AM Entera Bio Ltd. (ENTX) and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin Peptide Tablet Candidate
Sep 23, 2024 08:13AM OPKO Health's (OPK) ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
Sep 17, 2024 07:15AM Piper Sandler Reiterates Overweight Rating on Opko Health (OPK)
Sep 17, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
Aug 7, 2024 04:22PM OPKO Health (OPK) Tops Q2 EPS by 9c
Jul 18, 2024 08:00AM OPKO Health (OPK) Announces $100M Share Buyback
Jul 18, 2024 07:27AM Opko Health (OPK) PT Lowered to $3 at Piper Sandler